MOTS-c (Mitochondrial-Derived Peptide) | Educational Overview

What is MOTS-c?

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a naturally occurring 16-amino-acid peptide. Unlike the vast majority of peptides encoded by DNA inside the cell's nucleus, MOTS-c is unique because it is encoded entirely within the mitochondrial genome.

Often called an "exercise mimetic," MOTS-c acts as a critical metabolic signaling molecule that regulates systemic energy balance, cellular resilience, and bidirectional communication between the mitochondria and the nucleus. Endogenous (natural) levels of MOTS-c rise dramatically during physical stress or exercise, but they naturally decline as part of the aging process.

Key Benefits & Mechanisms of Action

1. Robust Activation of the AMPK Pathway

The primary mechanism of MOTS-c is the activation of AMP-activated protein kinase (AMPK), often described as the body's "master metabolic switch."

• Glucose Uptake: It signals skeletal muscle tissues to clear glucose from the bloodstream and utilize it efficiently for energy, closely mirroring the action of the first-line metabolic medication metformin.

• Fatty Acid Oxidation: It enhances the expression of carnitine shuttles, which transport fatty acids into the mitochondria to be broken down (beta-oxidation) for fuel, helping to prevent lipid accumulation in tissues.

  
  

2. Cellular Longevity and Anti-Aging

Because it addresses mitochondrial dysfunction—a primary hallmark of aging—preclinical research has highlighted its potential to support healthspan:

• Physical Capacity: In animal models, regular administration demonstrated marked improvements in grip strength, motor coordination, and endurance across all age brackets.

  
  

• Tissue Preservation: Studies indicate it plays a role in suppressing myostatin (an inhibitor of muscle growth) to combat age-related muscle wasting (sarcopenia), while supporting osteoblast differentiation to preserve bone density.

   

3. Adaptive Stress Resistance

When a cell undergoes metabolic stress, MOTS-c translocates directly into the cell nucleus to upregulate adaptive stress-response genes, boosting endogenous antioxidant pathways and downregulating pro-inflammatory markers.

Theoretical Dosing Guidelines (Research Use Only)

Important Regulatory Note: MOTS-c remains an experimental compound and is not approved by the FDA or international regulatory bodies for human use. The protocols below reflect common dosing parameters established within prevailing preclinical models, literature reviews, and clinical research contexts.

Because MOTS-c possesses a short half-life and acts primarily on systemic skeletal muscle tissue, it is typically administered via subcutaneous (SQ) injection.